News & Blog

Tag Archives: FDA

March 2018 Public Policy and Advocacy Updates

For a number of years now, our Public Policy & Advocacy staff have put out monthly emails to those who’ve signed-up to be NBTS volunteer advocates, providing updates on the latest goings-on in the world of brain tumor public policy and issues related to legislation that impacts this community. As our advocacy program continues to […]

Glossary Blog, February 2018: CAR T-Cell Therapy

CAR T-cell Therapy: A type of treatment in which a patient’s T-cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T-cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is […]

What the Brain Tumor Community Was Reading in 2017

This year we covered many topics on this blog, from stories of strength, determination, and dedication in the community; to news on research progress; clinical trial results and updates; innovation; and FDA approvals. We saw glioblastoma again enter the national consciousness, with the unfortunate news of Senator John McCain’s diagnosis (see below), as well as some […]

Share